Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Flow Chemistry Pump

By Drug Discovery Trends Editor | April 26, 2010

The Uniqsis FlowSyn flow chemistry system has an upgraded pump manifold that continuously monitors each high pressure reagent channel and alerts the user to any flow abnormalities, saving time and reagents by preventing experiments from continuing under erroneous conditions.

Reagent immiscibility, incomplete wetting of pump components, or the presence of static or transient air bubbles are the usual causes of the flow irregularities that occur during a run. In most cases, the problem can be corrected by re-priming the pump, aborting the experiment.

With the reagent manifold used in FlowSyn, the pump can be re-primed on the fly, so that the run can continue. Interlocks are provided so that if the error is not remedied within a specified period, the experiment is aborted. If an error condition is detected in one pump channel, the other is automatically stopped simultaneously until the problem is addressed.

New automatic injection valves with specially designed, highly inert rotor seals and larger diameter channels allow sample loops to be filled more quickly and are less easily blocked. These new valves can be retro-fitted to any FlowSyn unit with electrically operated injection valves. Vertical syringe ports mean that syringes can be left in place during a run to make re-priming easier.

Uniqsis  


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE